Certa Therapeutics

Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3
Fierce Biotech
Mon, 02/6/23 - 10:29 am
Certa Therapeutics
Shire
FT011
autoimmune disease
clinical trials
scleroderma